Shuanglu pharmaceutical Industry: Liang Shujie intends to reduce 0.0365% of the shares

Shuanglu Pharmaceutical announced that director and board secretary Liang Shujie holds 1,500,800 shares, accounting for 0.1461%; it is planned to reduce no more than 375,200 shares, accounting for 0.0365%, through centralized bidding within three months after the disclosure date of the announcement for fifteen trading days, with no reduction during the window period, and the reduction price will be determined based on the market price.